T. Rowe Price Associates’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.3M Sell
74,470
-1,498
-2% -$227K ﹤0.01% 1089
2025
Q1
$11.4M Sell
75,968
-95,251
-56% -$14.3M ﹤0.01% 1086
2024
Q4
$31.6M Sell
171,219
-1,687
-1% -$311K ﹤0.01% 878
2024
Q3
$34.1M Sell
172,906
-468,079
-73% -$92.2M ﹤0.01% 861
2024
Q2
$132M Sell
640,985
-681,469
-52% -$141M 0.02% 484
2024
Q1
$358M Sell
1,322,454
-120,721
-8% -$32.7M 0.04% 325
2023
Q4
$341M Sell
1,443,175
-237,498
-14% -$56.1M 0.05% 318
2023
Q3
$329M Sell
1,680,673
-815,821
-33% -$160M 0.05% 302
2023
Q2
$525M Sell
2,496,494
-9,799
-0.4% -$2.06M 0.07% 243
2023
Q1
$506M Buy
2,506,293
+653,790
+35% +$132M 0.08% 239
2022
Q4
$404M Buy
1,852,503
+266,004
+17% +$58M 0.06% 267
2022
Q3
$312M Buy
1,586,499
+482,207
+44% +$94.9M 0.05% 294
2022
Q2
$236M Buy
1,104,292
+883,029
+399% +$189M 0.03% 436
2022
Q1
$62.8M Buy
221,263
+1,892
+0.9% +$537K 0.01% 890
2021
Q4
$82.7M Sell
219,371
-2,413
-1% -$909K 0.01% 828
2021
Q3
$91.5M Sell
221,784
-65,081
-23% -$26.9M 0.01% 797
2021
Q2
$106M Buy
286,865
+39,642
+16% +$14.7M 0.01% 762
2021
Q1
$71.7M Sell
247,223
-19,630
-7% -$5.69M 0.01% 873
2020
Q4
$66.7M Sell
266,853
-18,600
-7% -$4.65M 0.01% 856
2020
Q3
$64.6M Sell
285,453
-112,229
-28% -$25.4M 0.01% 790
2020
Q2
$69.3M Sell
397,682
-207,395
-34% -$36.2M 0.01% 740
2020
Q1
$76.4M Buy
605,077
+15,868
+3% +$2M 0.01% 653
2019
Q4
$90M Buy
589,209
+17,323
+3% +$2.65M 0.01% 697
2019
Q3
$75.7M Buy
571,886
+17,783
+3% +$2.35M 0.01% 717
2019
Q2
$78.6M Sell
554,103
-1,382
-0.2% -$196K 0.01% 714
2019
Q1
$80.7M Sell
555,485
-191
-0% -$27.7K 0.01% 699
2018
Q4
$62.9M Buy
555,676
+8,236
+2% +$932K 0.01% 737
2018
Q3
$73.7M Buy
547,440
+45,839
+9% +$6.17M 0.01% 771
2018
Q2
$56.3M Buy
501,601
+53,525
+12% +$6.01M 0.01% 847
2018
Q1
$47.8M Buy
448,076
+14,852
+3% +$1.59M 0.01% 895
2017
Q4
$47.4M Buy
433,224
+38,712
+10% +$4.24M 0.01% 884
2017
Q3
$42.6M Buy
394,512
+40,174
+11% +$4.34M 0.01% 908
2017
Q2
$35.8M Buy
354,338
+16,928
+5% +$1.71M 0.01% 954
2017
Q1
$30.4M Buy
337,410
+40,803
+14% +$3.67M 0.01% 992
2016
Q4
$22.6M Sell
296,607
-5,677
-2% -$433K ﹤0.01% 1095
2016
Q3
$25.2M Buy
302,284
+16,970
+6% +$1.41M 0.01% 1050
2016
Q2
$23.5M Buy
285,314
+88,189
+45% +$7.27M 0.01% 1046
2016
Q1
$15M Buy
197,125
+182,732
+1,270% +$13.9M ﹤0.01% 1172
2015
Q4
$1.16M Sell
14,393
-5,349
-27% -$430K ﹤0.01% 1650
2015
Q3
$1.25M Buy
19,742
+211
+1% +$13.4K ﹤0.01% 1645
2015
Q2
$1.37M Buy
19,531
+5,130
+36% +$361K ﹤0.01% 1663
2015
Q1
$1.14M Buy
14,401
+74
+0.5% +$5.87K ﹤0.01% 1696
2014
Q4
$912K Buy
14,327
+266
+2% +$16.9K ﹤0.01% 1748
2014
Q3
$840K Buy
14,061
+1,405
+11% +$83.9K ﹤0.01% 1776
2014
Q2
$677K Sell
12,656
-904
-7% -$48.4K ﹤0.01% 1836
2014
Q1
$818K Buy
13,560
+1,992
+17% +$120K ﹤0.01% 1743
2013
Q4
$614K Sell
11,568
-6,600
-36% -$350K ﹤0.01% 1822
2013
Q3
$840K Sell
18,168
-2,400
-12% -$111K ﹤0.01% 1715
2013
Q2
$844K Buy
+20,568
New +$844K ﹤0.01% 1702